Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (IS) (2016 - 2019)

Xtant Medical Holdings (XTNT) has disclosed Depreciation & Amortization (IS) for 10 consecutive years, with $137000.0 as the latest value for Q3 2019.

  • Quarterly Depreciation & Amortization (IS) fell 86.69% to $137000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2019, down 66.64% year-over-year, with the annual reading at $4.1 million for FY2018, 24.92% down from the prior year.
  • Depreciation & Amortization (IS) for Q3 2019 was $137000.0 at Xtant Medical Holdings, down from $146000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $2.1 million in Q4 2015, with the low at $100663.0 in Q2 2015.
  • Average Depreciation & Amortization (IS) over 5 years is $989765.5, with a median of $1.2 million recorded in 2016.
  • The sharpest move saw Depreciation & Amortization (IS) skyrocketed 3606.51% in 2015, then tumbled 86.69% in 2019.
  • Over 5 years, Depreciation & Amortization (IS) stood at $2.1 million in 2015, then tumbled by 39.11% to $1.3 million in 2016, then grew by 10.36% to $1.4 million in 2017, then dropped by 24.35% to $1.0 million in 2018, then plummeted by 86.88% to $137000.0 in 2019.
  • According to Business Quant data, Depreciation & Amortization (IS) over the past three periods came in at $137000.0, $146000.0, and $159000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.